A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
Saved in:
| Title: | A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia. |
|---|---|
| Authors: | Vydra J; Institute of Haematology and Blood Transfusion, Prague, Czech Republic., Cosimo E; TC BioPharm, Motherwell, UK., Lesný P; Institute of Haematology and Blood Transfusion, Prague, Czech Republic., Wanless RS; TC BioPharm, Motherwell, UK., Anderson J; UCL Institute of Child Health, London, UK., Clark AG; TC BioPharm, Motherwell, UK., Scott A; TC BioPharm, Motherwell, UK., Nicholson EK; The Royal Marsden Hospital, London, UK., Leek M; TC BioPharm, Motherwell, UK. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 May; Vol. 23 (5), pp. e232-e239. Date of Electronic Publication: 2023 Feb 11. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2023.02.003 |
